1. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa
- Author
-
Kim Steegen, Kim C. E. Sigaloff, T. Sonia Boender, Mariette E. Botes, Pascale Ondoa, Tobias F. Rinke de Wit, Maureen Wellington, Raph L. Hamers, Immaculate Nankya, Margaret Siwale, Ragna S. Boerma, Job C. J. Calis, Alani S Akanmu, Cissy Kityo, Elizabeth Kaudha, Other departments, Graduate School, Global Health, Infectious diseases, AII - Amsterdam institute for Infection and Immunity, Paediatric Intensive Care, and Internal medicine
- Subjects
0301 basic medicine ,Microbiology (medical) ,Drug ,Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Anti-HIV Agents ,media_common.quotation_subject ,030106 microbiology ,HIV Infections ,Drug resistance ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Antiretroviral Therapy, Highly Active ,Genotype ,Drug Resistance, Viral ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Treatment Failure ,Young adult ,Child ,Africa South of the Sahara ,media_common ,Retrospective Studies ,Pharmacology ,business.industry ,Retrospective cohort study ,Viral Load ,Resistance mutation ,Reverse transcriptase ,Infectious Diseases ,Child, Preschool ,Mutation ,HIV-1 ,Reverse Transcriptase Inhibitors ,Female ,business ,Viral load - Abstract
Objectives Limited availability of viral load (VL) monitoring in HIV treatment programmes in sub-Saharan Africa can delay switching to second-line ART, leading to the accumulation of drug resistance mutations (DRMs). The objective of this study was to evaluate the accumulation of resistance to reverse transcriptase inhibitors after continued virological failure on first-line ART, among adults and children in sub-Saharan Africa. Methods HIV-1-positive adults and children on an NNRTI-based first-line ART were included. Retrospective VL and, if VL ≥1000 copies/mL, pol genotypic testing was performed. Among participants with continued virological failure (≥2 VL ≥1000 copies/mL), drug resistance was evaluated. Results At first virological failure, DRM(s) were detected in 87% of participants: K103N (38.7%), G190A (21.8%), Y181C (20.2%), V106M (8.4%), K101E (8.4%), any E138 (7.6%) and V108I (7.6%) associated with NNRTIs, and M184V (69.7%), any thymidine analogue mutation (9.2%), K65R (5.9%) and K70R (5.0%) associated with NRTIs. New DRMs accumulated with an average rate of 1.45 (SD 2.07) DRM per year; 0.62 (SD 1.11) NNRTI DRMs and 0.84 (SD 1.38) NRTI DRMs per year, respectively. The predicted susceptibility declined significantly after continued virological failure for all reverse transcriptase inhibitors (all P Conclusions Patterns of drug resistance after virological failure on first-line ART are similar in adults and children in sub-Saharan Africa. Improved VL monitoring to prevent accumulation of mutations, and new drug classes to construct fully active regimens, are required.
- Published
- 2017